...
search icon
orgo-img

Organogenesis Holdings Inc Share Price

ORGO
NAQ
$2.67
-$0.04
(-1.48%)
1D
Industry: Biotechnology Sector: Health Care

Organogenesis Holdings Inc Analyst Forecast

Organogenesis Holdings Inc Share Price Chart

Organogenesis Holdings Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$348.62M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
18.0667
Volume info-icon
This is the total number of shares traded during the most recent trading day.
668.52K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.39
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.61 L
$7.08 H
$2.67

About Organogenesis Holdings Inc, Common Stock

Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States. Its advanced wound care products include Affinity and Novachor, which are amnion and chorion placental allografts for use in the care of chronic and acute wounds as protective barriers and extracellular matrix (ECM) scaffolds; Apligraf, a bioengineered bi-layered skin substitute for the treatment of venous leg ulcers and diabetic foot ulcers (DFU); Dermagraft, a dermal substitute grown from human dermal fibroblasts to treat DFUs; NuShield, a dehydrated placental allograft and surgical barrier to provide a protective barrier and ECM scaffold to support native healing; PuraPly Antimicrobial (AM) and PuraPly SX, which are antimicrobial barriers for the management of open wounds in surgical settings; and CYGNUS Dual, VIA Matrix, and SimpliMax are placental tissue grafts used to treat chronic and acute wounds that can be stored at room temperature. The company also provides PuraPly MZ, a micronized version of PuraPly for the management of open wounds in surgical settings; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; FortiShield, a biosynthetic wound matrix for use as a temporary protective covering; and TransCyte, a bioengineered tissue scaffold that promotes burn healing. In addition, it develops ReNu, a cryopreserved suspension, which is in Phase 3 trial, for the management of symptoms associated with knee osteoarthritis; and placental products. The company serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician offices through direct sales representatives and independent agencies. Organogenesis Holdings Inc. is headquartered in Canton, Massachusetts. more

Industry: BiotechnologySector: Health Care

Organogenesis Holdings Inc Stock Returns

Time FrameORGOSectorS&P500
1-Week Return-6.97%-2.48%-1.18%
1-Month Return-28.99%-1.98%-2.14%
3-Month Return-44.03%-0.28%-1.73%
6-Month Return-47.02%9.61%3%
1-Year Return-49.62%4.85%21.8%
3-Year Return21.92%22.22%75.87%
5-Year Return-84.21%33.93%72.09%
10-Year Return-72.62%123.28%234.83%

Organogenesis Holdings Inc Financials

Dec '21Dec '22Dec '23Dec '24Dec '255YR TREND
Total Revenue467.36M450.89M433.14M482.04M564.17M[{"date":"2021-12-31","value":82.84,"profit":true},{"date":"2022-12-31","value":79.92,"profit":true},{"date":"2023-12-31","value":76.77,"profit":true},{"date":"2024-12-31","value":85.44,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Cost of Revenue114.20M105.02M106.48M115.74M149.11M[{"date":"2021-12-31","value":76.59,"profit":true},{"date":"2022-12-31","value":70.43,"profit":true},{"date":"2023-12-31","value":71.41,"profit":true},{"date":"2024-12-31","value":77.62,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Gross Profit353.16M345.87M326.66M366.30M415.06M[{"date":"2021-12-31","value":85.09,"profit":true},{"date":"2022-12-31","value":83.33,"profit":true},{"date":"2023-12-31","value":78.7,"profit":true},{"date":"2024-12-31","value":88.25,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Gross Margin75.57%76.71%75.42%75.99%73.57%[{"date":"2021-12-31","value":98.51,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.32,"profit":true},{"date":"2024-12-31","value":99.06,"profit":true},{"date":"2025-12-31","value":95.91,"profit":true}]
Operating Expenses280.94M323.57M314.13M367.58M358.68M[{"date":"2021-12-31","value":76.43,"profit":true},{"date":"2022-12-31","value":88.03,"profit":true},{"date":"2023-12-31","value":85.46,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":97.58,"profit":true}]
Operating Income72.22M22.30M12.53M(1.28M)56.38M[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":30.88,"profit":true},{"date":"2023-12-31","value":17.34,"profit":true},{"date":"2024-12-31","value":-1.78,"profit":false},{"date":"2025-12-31","value":78.08,"profit":true}]
Total Non-Operating Income/Expense(16.37M)(4.03M)(3.79M)(3.07M)(7.13M)[{"date":"2021-12-31","value":-1636800000,"profit":false},{"date":"2022-12-31","value":-403100000,"profit":false},{"date":"2023-12-31","value":-379100000,"profit":false},{"date":"2024-12-31","value":-306800000,"profit":false},{"date":"2025-12-31","value":-713400000,"profit":false}]
Pre-Tax Income63.09M20.28M10.39M(2.81M)46.97M[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":32.15,"profit":true},{"date":"2023-12-31","value":16.47,"profit":true},{"date":"2024-12-31","value":-4.45,"profit":false},{"date":"2025-12-31","value":74.45,"profit":true}]
Income Taxes(31.12M)4.75M5.45M(3.67M)9.94M[{"date":"2021-12-31","value":-313.1,"profit":false},{"date":"2022-12-31","value":47.8,"profit":true},{"date":"2023-12-31","value":54.81,"profit":true},{"date":"2024-12-31","value":-36.91,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]
Income After Taxes94.20M15.53M4.95M861.00K37.03M[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":16.49,"profit":true},{"date":"2023-12-31","value":5.25,"profit":true},{"date":"2024-12-31","value":0.91,"profit":true},{"date":"2025-12-31","value":39.31,"profit":true}]
Income From Continuous Operations94.90M15.53M13.00M861.00K37.03M[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":16.37,"profit":true},{"date":"2023-12-31","value":13.7,"profit":true},{"date":"2024-12-31","value":0.91,"profit":true},{"date":"2025-12-31","value":39.02,"profit":true}]
Income From Discontinued Operations-----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income94.20M15.53M4.95M861.00K37.03M[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":16.49,"profit":true},{"date":"2023-12-31","value":5.25,"profit":true},{"date":"2024-12-31","value":0.91,"profit":true},{"date":"2025-12-31","value":39.31,"profit":true}]
EPS (Diluted)0.710.180.040.180.25[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":24.79,"profit":true},{"date":"2023-12-31","value":5.03,"profit":true},{"date":"2024-12-31","value":25.75,"profit":true},{"date":"2025-12-31","value":35.61,"profit":true}]

Organogenesis Holdings Inc Ratios

Organogenesis Holdings Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

ORGO
Cash Ratio 0.94
Current Ratio 3.62
Quick Ratio 3.32

Organogenesis Holdings Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ORGO
ROA (LTM) 6.43%
ROE (LTM) 9.04%

Organogenesis Holdings Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ORGO
Debt Ratio Lower is generally better. Negative is bad. 0.28
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.72

Organogenesis Holdings Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ORGO
Trailing PE 18.07
Forward PE 12.32
P/S (TTM) 0.62
P/B 1.17
Price/FCF 10
EV/R 0.84
EV/Ebitda 5.70

FAQs

What is Organogenesis Holdings Inc share price today?

Organogenesis Holdings Inc (ORGO) share price today is $2.67

Can Indians buy Organogenesis Holdings Inc shares?

Yes, Indians can buy shares of Organogenesis Holdings Inc (ORGO) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ORGO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Organogenesis Holdings Inc be purchased?

Yes, you can purchase fractional shares of Organogenesis Holdings Inc (ORGO) via the Vested app. You can start investing in Organogenesis Holdings Inc (ORGO) with a minimum investment of $1.

How to invest in Organogenesis Holdings Inc shares from India?

You can invest in shares of Organogenesis Holdings Inc (ORGO) via Vested in three simple steps:

  • Click on Sign Up or Invest in ORGO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Organogenesis Holdings Inc shares
What is Organogenesis Holdings Inc 52-week high and low stock price?

The 52-week high price of Organogenesis Holdings Inc (ORGO) is $7.08. The 52-week low price of Organogenesis Holdings Inc (ORGO) is $2.61.

What is Organogenesis Holdings Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Organogenesis Holdings Inc (ORGO) is 18.0667

What is Organogenesis Holdings Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Organogenesis Holdings Inc (ORGO) is 1.17

What is Organogenesis Holdings Inc dividend yield?

The dividend yield of Organogenesis Holdings Inc (ORGO) is 0.00%

What is the Market Cap of Organogenesis Holdings Inc?

The market capitalization of Organogenesis Holdings Inc (ORGO) is $348.62M

What is Organogenesis Holdings Inc's stock symbol?

The stock symbol (or ticker) of Organogenesis Holdings Inc is ORGO

How Can Investors Use Organogenesis Holdings Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Organogenesis Holdings Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Organogenesis Holdings Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Organogenesis Holdings Inc shares for Indian investors?

When investing in Organogenesis Holdings Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Organogenesis Holdings Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Organogenesis Holdings Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Organogenesis Holdings Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Organogenesis Holdings Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top